Chikara Ogawa

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

Masatoshi Kudo, Sadahisa Ogasawara, Shuntaro Obi et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 309 citations · Full text

Medicine, Oncology, Pharmacology +15

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan et al. · Cancers · 2019 · 298 citations · Full text

Medicine, Oncology, Surgery +14

Efficacy of probiotic treatment with <i>Bifidobacterium longum 536</i> for induction of remission in active ulcerative colitis: A randomized, double‐blinded, placebo‐controlled multicenter trial

Hiroyuki Tamaki, Hiroshi Nakase, Satoko Inoue et al. · Digestive Endoscopy · 2015 · 214 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacotherapy +16

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara et al. · Cancers · 2019 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima et al. · Liver Cancer · 2023 · 144 citations · Full text

Medicine, Oncology, Pharmacotherapy +17